glp-1 amplifier GLP-1-directed NMDA receptor antagonism for obesity treatment GLP-1 Amplifier – Natural GLP-1
Description
Access the complete GLP-1 Pipeline Update table for August 2025

Semaglutide is a GLP-1 receptor agonist that is also currently approved for the treatment of type 2 diabetes and obesity

2009 Oct;5(10):749-57

If you have type 2 diabetes and are concerned about your overall brain health, here are steps you can take: Talk to your doctor: Ask whether GLP-1 drugs are appropriate for you based on your overall health and blood sugar levels

FOR OZEMPIC IS APPROVED SOURCE: DailyMed

**GLP-1 Medications are only prescribed if your doctor finds them appropriate